Clinical trials
Recruiting Graft vs Host Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 13 |
| 2025 | 22 |
| 2026 | 13 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 74 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 4 |
| City of Hope Medical Center | 3 |
| The First Affiliated Hospital of Soochow University | 3 |
| Dana-Farber Cancer Institute | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Novartis Pharmaceuticals | 2 |
| Tata Memorial Centre | 2 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2 |
| WeiShi | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 74 |
| Hematologic Neoplasms | 15 |
| Myelodysplastic Syndromes | 12 |
| Bronchiolitis Obliterans Syndrome | 10 |
| Leukemia, Myeloid, Acute | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Hodgkin Disease | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Neoplasms | 4 |
| Leukemia | 3 |
Trials
Showing 76 to 74 of 74. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.